Targeting gene therapy vectors to CNS malignancies

Reference

• Aboody-Guterman K., Seena-Esteves M., Herrlinger U., Synder E. Y. Breakfield XO Visualization of brain tumor growth and neural cell migration in vivo using retroviral vectors expressing GFP. Soc Neurosci 1996; 22: 949
   Google Scholar
• Aho R., Jakanen S., Kalimo H. CD44-hyaluronate interaction mediates in vitro lymphocyte binding to the white matter of the central nervous system. J Neuropath 1994; 53: 295–302
   Google Scholar
• Albritton L. M., Tseng L., Scadden D., Cunningham JM. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1995; 57: 659–666
   Google Scholar
• Arbuthnot P., Bralet M. P., Thamassin H., Danan J. L., Brechot C., Ferry N. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alph-fetoprotein but no insulinlike growth factor II regulatory sequences. Hepatology 1995; 22: 1788–1796
   Google Scholar
• Arteaga C. L., Holt JT. Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice. Cancer Res 1996; 56: 1098–1103
   Google Scholar
• Bartus R. T., Elliott P. J., Dean R. L., Hayward N. J., Nagle T. L., Huff M. R., Snodgrass P. A., Blunt DG. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp Neurol 1996; 142: 14–28
   PubMed Web of Science ®Google Scholar
• Ben-Shacher D., Yehuda S., Finberg JPM, Spanier I., Youdim MBH. Selective alteration of the blood-brain barrier and insulin transport in iron-deficient rats. J Neurochem 1988; 50: 1434–1437
   Google Scholar
• Berens M. E., Rutka J. T., Rosenblum ML. Brain tumor epidemiology, growth, and invasion. Neurosurg Clin N Am 1990; 1: 1–18
   PubMedGoogle Scholar
• Bergstrom M., Collins V. P., Ehrin E., Ericson K., Eriksson L., Greitz T., Halldin C., Von Hoist H., LangstrÖM B., Lilj A., Lundquist H., Nagren K. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C] methionine. J Comput Assist Tomogr 1983; 7: 1062–1066
   Google Scholar
• Besnard F., Brenner M., Nakatani Y., Chao R., Purohit H. J., Freese E. Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein. J Biol Chem 1991; 266: 18877–18883
   PubMed Web of Science ®Google Scholar
• Bigner D. D., Brown M., Coleman R. E., Friedman A. H., Friedman H. S., Mclendon R. E., Signer S. H., Zhao X. G., Wikstrand C. J., Pegram CN, et al. Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Mel-14F(ab′)2 - a preliminary report. J Neurooncol 1995; 24: 109–122
   PubMed Web of Science ®Google Scholar
• Bischoff J. R., Kirn D. H., Williams A., Heise C., Horn S., Muna M., Ng L., Nye J. A., Sampson-Johannes A., Fattaey A., Mccormick F. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996; 274: 373–376
   PubMed Web of Science ®Google Scholar
• Boothman D. A., Lee I. W., Sahijdak WM. Isolation of an x-ray-responsive element in the promoter region of tissue-type plasminogen activator: potential uses of x-ray-responsible elements for gene therapy. Rad Res 1994; 138: S68–71
   Google Scholar
• Boucher Y., Leunig M., Jain RK. Tumor angiogenesis and interstitial hypertension. Cancer Res 1996; 56: 4264–4266
   PubMed Web of Science ®Google Scholar
• Brach M. A., Hass R., Sherman M. L., Gunji H., Weichselbaum R., Kufe D. Ionizing radiation induces expression and binding activity of the nuclear factor kappa b. J Clin Invest 1991; 88: 691–695
   PubMed Web of Science ®Google Scholar
• Braselmann S., Graninger P., Busslinger M. A selective transcriptional induction system for mammalian cells based on Ga14-estrogen receptor fusion proteins. Proc Natl Acad Sci 1993; 90: 1657–1661
   PubMed Web of Science ®Google Scholar
• Brenner M., Kisseberth W. C., Su Y., Besnard F., Messing A. GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 1994; 14: 1030–1037
   PubMed Web of Science ®Google Scholar
• Camp B. J., Dyhrman S. T., Memoli V. A., Mott L. A., Barth RJ. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Annals of Surgical Oncology 1996; 3: 176–184
   PubMed Web of Science ®Google Scholar
• Chen L., Chen D., Manome Y., Dong Y., Fine H. A., Kufe DW. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J Clin Invest 1995; 96: 2775–2782
   PubMed Web of Science ®Google Scholar
• Cheng PW. Receptor Ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther 1996; 7: 275–282
   PubMed Web of Science ®Google Scholar
• Chiocca E. A., Andersen J., Takamiya Y., Martuza R., Breakefield XO. Virus-mediated genetic treatment of rodent gliomas. Gene Therapeutics, JA Wolf. Boston, Birkhauser 1994; 245–262
   Google Scholar
• Chu T. H., Marinez I., Sheay W. C., Dornberg R. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Therapy 1994; 1: 292–299
   Google Scholar
• Cole D. J., Weil D. P., Shilyanski J., Custer M., Kawakami Y., Rosenberg SA. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen. Cancer Res 1995; 55: 748–752
   PubMed Web of Science ®Google Scholar
• Cosset F. L., Morling F. J., Takeuchi Y., Weiss R. A., Collins M. K., Russell SJ. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 1995; 69: 6314–6322
   PubMed Web of Science ®Google Scholar
• Christiano R., Roth J. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther 1996; 3: 4–10
   Google Scholar
• Culver K. W., Ram Z., Walbridge S., Ishii H., Oldfield E. H., Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550–1552
   PubMed Web of Science ®Google Scholar
• Datta R., Rubin E., Suchatme V., Qureshi S., Halahan D., Weichselbaum R. R., Kufe DW. Ionizing radiation activates transcription of the EGRl gene via CArG elements. Proc Natl Acad Sci USA 1992; 89: 10149–10153
   PubMed Web of Science ®Google Scholar
• Dimaio J. M., Clary B. M., Via Df Coveney E., Pappas T. N., Lyerly HK. Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery 1994; 116: 205–213
   PubMed Web of Science ®Google Scholar
• Ding D., Toth M., Zhou Y., Parks C., Hoffman B. J., Shenk T. Glial cell specific expression of the serotonin 2 receptor gene: selective reactivation of a repressed promoter. Brain Res Mol Brain Res 1993; 20: 181–191
   Google Scholar
• Doran S. E., Dan Ren X., Betz A. L., Pagel M. A., Neuwelt E. A., Roessler B. J., Davidson BL. Gene expression from recombinant viral vectors in the CNS following blood-brain-barrier disruption. Neurosurgery 1995; 36: 965–970
   PubMed Web of Science ®Google Scholar
• Dore-Duffy P., Balabanov R., Washington R., Swanborg RH. Transforming growth factor beta 1 inhibits cytokine-induced CNS endothelial cell activation. Mol & Chem Neuropath 1994; 22: 161–175
   PubMedGoogle Scholar
• Elliott P. J., Hayward N. J., Huff M. R., Nagle T. L., Black K. L., Bartus RT. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy. Exp Neurol 1996; 141: 214–224
   PubMed Web of Science ®Google Scholar
• Emanuel N., Kedar E., Bolotin E. M., Smorodinsky N. I., Barenholz Y. Targeted delivery of duxorubicin via sterically stabilized immunoliposomes: pharmaco-kinetics and biodistribution in tumor-bearing mice. Pharm Res 1996; 13: 861–868
   PubMed Web of Science ®Google Scholar
• Engelhardt B., Conley F., Kilshaw P., Butcher EC. Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not MAdCAM-1. Int Immunol 1995; 7: 481–491
   PubMed Web of Science ®Google Scholar
• Ferrari G., Salvatori G., Rossi C., Cossu G., Mavilio F. A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. Hum Gene Ther 1995; 6: 733–742
   Google Scholar
• Fisher B., Packard B. S., Read E. J., Carrasquillo J. A., Carter C. S., Topalian S. L., Yang J. C., Yolles P., Larson S. M., Rosenberg SA. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol 1989; 7: 250–261
   PubMed Web of Science ®Google Scholar
• Fishman G. I., Kaplan M. L., Buttrick PM. Tetracyclin-regulated cardiac gene expression in vivo. J Clin Invest 1994; 93: 1864–1868
   PubMed Web of Science ®Google Scholar
• Fishman J. B., Rubin J. B., Handrahan J. V., Connor J. R., Fine RE. Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res 1987; 19: 299–304
   Google Scholar
• Frieden PM. Receptor-mediated transport of peptides and proteins across the blood-brain barrier. The Blood-Brain Barrier, WM Pardridge. Raven Press, Ltd., New York 1993a; 229–247
   Google Scholar
• Frieden P. M., Walus L. R., Musso G. F., Taylor M. A., Malfroy B., Starzyk RM. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci USA 1991; 88: 4771–4775
   PubMed Web of Science ®Google Scholar
• Frieden P. M., Walus L. R., Watson P., Doctrow S. R., Kozarich J. W., Backman C., Bergman H., Hoffer B., Bloom F., Granhom AC. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 1993b; 259: 373–377
   PubMed Web of Science ®Google Scholar
• Gao L., Wagner E., Cotten M., Agarwal S., Harris C., Romer M., Miller L., Hu P. C., Curiel D. Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes. Hum Gene Ther 1993; 4: 17–24
   PubMed Web of Science ®Google Scholar
• Gazit G., Kane S. E., Nichols P., Lee ES. Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Res 1995; 55: 1660–1663
   PubMed Web of Science ®Google Scholar
• Gherzi R., Carnemolla B., Siri A., Ponassi M., Balza E., Zardi L. Human tenascin gene. Structure of the 5′-region, identification, and characterization of the transcription regulatory sequences. J Biol Chem 1995; 270: 3429–3434
   PubMedGoogle Scholar
• Gladson C. L., Cheresh DA. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 1991; 88: 1924–1932
   PubMed Web of Science ®Google Scholar
• Gladson C. L., Wilcox J. N., Sanders L., Gillespie G. Y., Cheresh DA. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Science 1995; 108: 947–956
   PubMed Web of Science ®Google Scholar
• Goldsmith K. T., Curiel D. T., Engler J. A., Garver RI. Trans complementation of an ElA-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells. Hum Gene Ther 1994; 5: 1341–1348
   PubMed Web of Science ®Google Scholar
• Goldstein D. J., Veller SK. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J Virol 1988; 62: 196–205
   PubMed Web of Science ®Google Scholar
• Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl. Acad Sci 1992; 89: 5547–5551
   PubMed Web of Science ®Google Scholar
• Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., Bujanrd H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766–1769
   PubMed Web of Science ®Google Scholar
• Gottschalk S., Cristiano R., Smith L., Wood SL. Folate receptor-mediated DNA delivery and expression in vitro. Gene Ther 1994; 1: 185–191
   PubMed Web of Science ®Google Scholar
• Gray K. D., Roth MJ. Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol 1993; 67: 3489–3496
   Google Scholar
• Greenwood J., Wang Y., Calder VL. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunol 1995; 86: 408–415
   PubMed Web of Science ®Google Scholar
• Griffith K. D., Read E. J., Carrasquillo J. A., Carter C. S., Yang J. C., Fisher B., Aebersold P., Packard B. S., Yu M. Y., Rosenberg SA. In vivo distribution of adoptively transferred indium-lll-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst 1989; 81: 1709–1717
   PubMed Web of Science ®Google Scholar
• Gross G., Waks T., Eshar Z. Expression of immunoglobulin T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci USA 1989; 86: 10024–10028
   PubMed Web of Science ®Google Scholar
• Gutin P. H., Prados M. D., Phillips T. L., Wara W. M., Larson D. A., Leibel S. A., Sneed P. K., Levin V. A., Weaver K. A., Silver P, et al. External irradiation followed by an intersittial high activity iodine-125 implant ‘boost’ in the initial treatment of malignant gliomas: NCOG study 6G-82–2. Int J Radiat Oncol Biol Phys 1991; 21: 601–606
   PubMed Web of Science ®Google Scholar
• Hallahan D. E., Kataoka Y., Kuchibhotla J., Virudachalam S., Weischelbaum R. Tissue specific promoters improve the localization of radiation-inducible gene expression. Int J Radiat Oncol Biol Phys 1996; 36((Suppl))226, (abstr 136)
   Google Scholar
• Hallahan D. E., Mauceri H. J., Seung L. P., Dunphy E. J., Wayne J. D., Hanna N. N., Toledano A., Helman S., Kufe D. W., Weischelbaum RR. Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1995; 8: 786–791
   Google Scholar
• Hallahan D. E., Spriggs D. R., Beckett M. A., Kufe DW. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 1989; 86: 10104–10107
   PubMed Web of Science ®Google Scholar
• Han X., Kasahara N., Kan YW. Ligand-directed retroviral targeting of human breast cancer cells. Proc. Natl Acad Sci 1995; 92: 9747–9751
   PubMed Web of Science ®Google Scholar
• Hatva E., Kaipainen A., Mentula P., Jaaskelainen J., Paetau A., Haltia M., Alitalo K. Expression of endothelial cell-specific receptor tyrosine kinases growth factors in human brain tumors. Am J Path 1995; 146: 368–378
   PubMed Web of Science ®Google Scholar
• Henson JW. Regulation of the glial specific JC virus early promoter by the transcription factor Sp 1. J Biologic Chem 1994; 269: 1046–1050
   Google Scholar
• Higuchi M., Ohnishi T., Arita N., Hiraga S., Hayakawa T. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dediffer-entiation and angiogenesis. Acta Neuropathol 1993; 85: 481–484
   PubMed Web of Science ®Google Scholar
• Huang K., Geoffroy J. S., Singer M. S., Rosen S. A lymphocyte homing receptor (L-selectin) mediates the in vitro attachment of lymphocytes to myelinated tracts to the central nervous system. J Clin Invest 1991; 88: 1778–1783
   PubMed Web of Science ®Google Scholar
• Hurford R. K., Dranoff G., Mulligan R. C., Tepper RI. Gene Therapy of metastatic cancer by in vivo retroviral gene targeting. Nat Genetics 1995; 10: 430–435
   PubMed Web of Science ®Google Scholar
• Huwyler J., Wu D., Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci 1996; 93: 14164–14169
   PubMed Web of Science ®Google Scholar
• Hwu P., Rosenberg SA. Gene Therapy of cancer. Cancer: principles and practice of oncology. Fifth, V. T. Devita, S Hellman, SA Rosenberg. Lippincott-Raven Publishers, Philadelphia 1997; 3005–3022
   Google Scholar
• Hwu P., Yang J. C., Cowher R., Treisman J., Shafer G. E., Eshar Z., Rosenberg SA. In vivo antitumor activity of T-cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res 1995; 55: 3369–3373
   PubMed Web of Science ®Google Scholar
• Hwu P., Yannelli J., Kriegler M., Anderson W. F., Perez C., Chiang Y., Schwarz S., Cowherd R., Delgado C., Mule J, et al. Functional and molecular characterization of TIL transduced with TNFa cDNA for the gene therapy of cancer in man. J Immunol 1993; 150: 4104–4115
   PubMed Web of Science ®Google Scholar
• Inamura T., Black KL. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab 1994; 14: 862–870
   PubMed Web of Science ®Google Scholar
• Inoue M., Plautz G., Shu S. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells. Cancer Res 1996; 56: 4702–4708
   PubMed Web of Science ®Google Scholar
• Ioannides C. G., Fisk B., Tomasovic B., Pandita R., Aggarwal B. B., Freedman RS. Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes. Cancer Immunol Immunother 1992; 35: 83–91
   Google Scholar
• Ishihara H., Tsuneoka K., Dimchev A. B., Shikita M. Induction of the expression of the interleukin-1 beta gene in mouse spleen by ionizing radiation. Radiat Res 1993; 133: 321–326
   PubMedGoogle Scholar
• Ito T., Recht L., Salimi A., Brill A. B., Raso V., Griffin T. Delivery of antitransferrin receptor MABS into human glioma xenografts: autoradiographic studies (abstr.). Proc Annu Meet Am Assoc Cancer Res 1991; 32: A1608
   Google Scholar
• Ikoh K., Tilden A. B., Balch CM. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res 1986; 46: 3011–3017
   Google Scholar
• Jaworski D. M., Kelly G. M., Piepmeier J. M., Hockfield S. BEHAB (Brain Enriched Hyaluronan Binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Res 1996; 56: 2293–2298
   Google Scholar
• Jefferies W. A., Brandon M. R., Hunt S. V., Williams A. F., Gatter K. C., Mason DY. Transferrin receptor on endothelium of brain capillaries. Nature 1984; 312: 162–163
   PubMed Web of Science ®Google Scholar
• Kasahara N. K., Dozy A. M., Kan YW. Tissue specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373–1375
   PubMed Web of Science ®Google Scholar
• Kesari S., Randazzo B. P., Valyi-Nagy T, et al. Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. Lab Invest 1995; 73: 636–648
   PubMed Web of Science ®Google Scholar
• Kim J. H., Kim S. H., Kolzsvary B. S., Brown S. L., Kim O. B., Freytag SO. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cell in vitro and in vivo by antiviral agents. Int J Radiat Oncol Biol Phys 1995; 33: 861–868
   PubMed Web of Science ®Google Scholar
• Kim J. H., Kim S. H., Brown S. L., Freytag SO. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSVtk gene. Cancer Res 1994; 54: 6053–6056
   PubMed Web of Science ®Google Scholar
• Ko S. C., Cheon J., Kao C., Gotoh A., Shirakawa T., Sikes R. A., Karsenty G., Chung LWK. Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models. Cancer Res 1996; 56: 4614–4619
   PubMed Web of Science ®Google Scholar
• Kondratyev A. D., Chung K. N., Jung MO. Identification and characterization of a radiationinducible glycosylated human early-response gene. Cancer Res 1996; 56: 1498–1502
   PubMedGoogle Scholar
• Kramer R., Zhang Y., Gehrmann J., Gold R., Thoenen H., Wekerle H. Gene transfer through the blood nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autimmune neuritis. Nat Med 1995; 1: 1162–1166
   Google Scholar
• Kramm C. M., Rainov N. G., Sena-Esteves M., Barnett F. H., Chase M., Herllinger U., Pechan P., Chiocca E. A., Breakefield XO. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment. Hum Gene Ther 1996; 7: 1989–1994
   PubMed Web of Science ®Google Scholar
• Kramm C. M., Sena-Esteves M., Barnett F. H., Rainov N. G., Schuback D. E., Yu J. S., Pechan P. A., Paulus W., Chiocca E. A., Breakefield XO. Gene Therapy for brain tumors. Brain Pathol 1995; 5: 345–381
   PubMed Web of Science ®Google Scholar
• Krebs C. J., Mcavoy M. T., Kumar G. The JC virus minimal core promoter is glial cell specific in vivo. J Virol 1994; 69: 2434–2442
   Google Scholar
• Kristiansen K., Hagen S., Kollevold T., Torvik A., Holme I., Nesbakken R., Hatlevoll R., Lindgren M., Brun A., Lindgren S., Notter G., Andersen A. P., Elgen K. Combined modality therapy of operated astrocytomas grade III and IV: confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981; 47: 649–652
   PubMed Web of Science ®Google Scholar
• Kumagai T., Tanio Y., Osaki T., Horai T., Kishimoto T. Gene Therapy for small cell lung cancer cells over-expressing myc family oncogenes by tumour-specific expression of the herpes simplex virus thymidine kinase gene. Gene. Ther 1995; 2: 33–41
   Google Scholar
• Kuppner M. C., Hamou M. F., De Tribolet N. Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. Cancer Res 1988; 48: 6926–6932
   PubMed Web of Science ®Google Scholar
• Kurnick J. T., Kradin R. L., Blumberg R., Schneeberger E. E., Boyle LA. Functional characterization of T lymphocytes propagated from human lung carcinomas. Clin Immunol Immunopathol 1986; 38: 367–380
   Google Scholar
• Ladner R. C., Guterman SK. 1990, PCT patent application W090/02809.
   Google Scholar
• Lafreniere R., Rosenberg SA. Successful irnmunotherapy of mutine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin-2. Cancer Res 1985; 45: 3735–3741
   PubMed Web of Science ®Google Scholar
• Lai B., Indurti R. R., Couraud P. O., Goldstein GW, Laterra J. Endothelial cell implantation and survival within experimental gliomas. Proc Natl Acad Sci 1994; 91: 9695–9699
   Google Scholar
• Laske D. W., Ilercil O., Akbasak A., Youle R. J., Oldfield EH. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. J Neurosurg 1994; 80: 520–526
   PubMed Web of Science ®Google Scholar
• Lee C. H., Liu M., Sie K. L., Lee MS. Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-a and topoisomerase Iia in prostate cancer. Anticancer Res 1996; 16: 1805–1812
   PubMed Web of Science ®Google Scholar
• Lee Y., Bullard D. E., Humphry P. A., Colapinto E. V., Friedman H. S., Zalutsky M. R., Coleman R. E., Bigner DD. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6. Cancer Res 1988; 48: 2904–2910
   PubMed Web of Science ®Google Scholar
• Levine A. J., Momand J., Finlay CA. The p53 tumour suppressor-gene. Nature 1991; 351: 453–456
   PubMed Web of Science ®Google Scholar
• Levy A. P., Lev N. S., Wegner S., Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1955; 270: 13333–13340
   Google Scholar
• Linington C., Berger T., Perry L., Weerth S., Hinze-Selch D., Zhang Y., Lu H., Lassmann H., Wkerle H. T cells specific for the myelin oligodendricyte glycoprotein mediate an unusual auto immune inflammatory response in the central nervous system. Eur J Immunol 1993; 23: 1364–1372
   PubMed Web of Science ®Google Scholar
• Lu B., Federoff HJ. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum Gene Ther 1995; 6: 419–428
   PubMed Web of Science ®Google Scholar
• Lubbe A. S., Bergemann C., Riess H., Schriever F., Reichardt P., Possinger K., Matthias M., Dorken B., Herrmann F., Gurtler R., Hohenberger P., Haas N., Sohr R., Sander B., Lemke A. J., Ohlendorf D., Huhnt W., Huhn D. Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 1996; 56: 4686–4693
   PubMed Web of Science ®Google Scholar
• Martin M., Noel D., Valsesia-Wittman S., Brockly F., Etienne-Julan M., Russell S., Cosset F. L., Piechaczyk M. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J Virol 1996; 70: 2957–2962
   Google Scholar
• Martell L. A., Agrawal A., Ross D. A., Muraszko KM. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res 1993; 53: 1348–1353
   PubMed Web of Science ®Google Scholar
• Martuza R. L., Malick A., Markert J. M., Ruffner K. L., Coen DM. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991; 252: 854–856
   PubMed Web of Science ®Google Scholar
• Matsuoka S., Yamaguchi M., Hiyashi Y., Matsukage A. Nucleotide sequence and promoter-specific effect of a negative regulatory region located upstream of the mouse proliferating cell nuclear antigen gene. Eur J Biochem 1993; 218: 173–181
   Google Scholar
• Mckie E. A., Maclean A. R., Lewis AD, et al. Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumors- evaluation of potentially effective clinical therapy. Br J Cancer 1996; 75: 745–752
   Google Scholar
• Michael S. I., Hong J. S., Curiel D. T., Engler JA. Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther 1995; 2: 660–668
   PubMed Web of Science ®Google Scholar
• Miescher S., Whiteside T. L., Moretta L., Von Fliedner V. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. J Immunol 1987; 142: 4004–4011
   Google Scholar
• Miyao Y., Shimizu K., Moriuchi S., Yamada M., Nakahira K., Nakajima K., Nakao J., Kuriyama S., Tusjii T., Mikoshiba K., Hayakawa T., Ikenaka K. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression. J Neurosci Res 1993; 36: 472–479
   PubMed Web of Science ®Google Scholar
• Mule J. J., Shu S., Rosenberg SA. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 1984; 225: 1487
   PubMed Web of Science ®Google Scholar
• Myers R. L., Ray S. K., Eldridge R., Chotani M. A., Chiu IM. Functional characterization of the brain-specific FGF-1 promoter, FGF-l.B. J Biol Chem 1995; 270: 8257–8266
   PubMedGoogle Scholar
• Negrier S., Philip T., Stoter G., Fossa S. D., Janssen S., Iacone A., Cleton F. S., Eremin O., Israel L., Jasmin C, et al. Interleukin-2 with or without LAK cell in metastatic renal cell carcinoma: A report of a European multicentre study. Eur J Cancer Clin Onco 1989; 25: S21–S28
   Google Scholar
• Nerrouche Y., Negrier S., Bain C., Combaret V., Mercatello A., Coronel B. Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin. J Clin Oncol 1995; 13: 410–417
   Google Scholar
• Netti P. A., Baxter L. T., Boucher Y., Skalak R., Jain RK. Time-dependent behavior of intersittial fluid pressure in solid tumors: implications for drug delivery. Cancer Res 1995; 55: 5451–5458
   PubMed Web of Science ®Google Scholar
• Neuwelt E. A., Hill SA. Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastates. J Neuro-oncol 1987; 4: 195–207
   PubMed Web of Science ®Google Scholar
• Nilaver G., Muldoon L. L., Kroll R. A., Pagel M. A., Breakefield X. O., Davidson B. L., Neuwelt EA. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors following osmotic blood-brain barrier disruption. Proc Natl Acad Sci 1995; 92: 9829–9833
   PubMed Web of Science ®Google Scholar
• O'Neil K. T., Hoess RH. Phage display: protein engineering by directed evolution (review). Cur Opinion Struct Biol 1995; 5: 443–449
   Google Scholar
• Oldfield E. H., Ram Z., Culver K. W., Blaese R. M., Devroom H. L., Anderson WF. Gene Therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993; 4: 39–69
   PubMed Web of Science ®Google Scholar
• Osaki T., Tanio Y., Tachibana I., Hosoe S., Kumagai T., Kawase I., Oikawa S., Kisismoto T. Gene Therapy for carcinoembryonic antigen-producing human lung cancer cells by cell-type specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 1994; 54: 5258–5261
   PubMed Web of Science ®Google Scholar
• Ozaki K., Yoshida T., Ide H., Saito I., Ideda Y., Sugimura T., Terada M. Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC. Hum Gene Ther 1996; 7: 1483–1490
   Google Scholar
• Paine J. T., Handa H., Yamasaki T., Yamashita J., Miyatake S. Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors. Neurosurg 1986; 18: 766–772
   Google Scholar
• Pang S., Dannul L. J., Kaboo R., Xie Y., Tso C., Michel K., De Kernion J. B., Belldegrun AS. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Cancer Res 1996; 57: 495–499
   Google Scholar
• Papa M. Z., Mule J. J., Rosenberg SA. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: Successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogemc murine tumors of three distict histological types. Cancer Res 1986; 46: 4973–4978
   PubMed Web of Science ®Google Scholar
• Parmley S. F., Smith GP. Antibody-selectable filamentous fd phage vectors: Affinity purification of target genes. Gene 1989; 73: 305–318
   Google Scholar
• Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996; 380: 364–366
   PubMed Web of Science ®Google Scholar
• Paulus W., Baur I., Boyce F. M., Breakefield X. O., Reeves SA. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70: 62–67
   PubMed Web of Science ®Google Scholar
• Pechan P. A., Fotaki M., Thompson R. L., Dunn R., Chase M., Chiocca E. A., Breakefield XO. A novel ‘piggyback’ packaging system for herpes simplex virus amplicon vectors. Hum Gene Ther 1996; 7: 2003–2013
   PubMed Web of Science ®Google Scholar
• Peter R. U., Beetz A., Ried C., Michel G., Van Beuningen D., Ruzicka T. Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation. Radiat Res 1993; 136: 65–70
   PubMed Web of Science ®Google Scholar
• Plate K. H., Breier G., Weich H. A., Mennel H. D., Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994; 59: 520–529
   PubMed Web of Science ®Google Scholar
• Rabinowich H., Cohen R., Bruderman I. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res 1987; 47: 173–177
   PubMed Web of Science ®Google Scholar
• Rainov N. G., Zimmer C., Chase M., Kramm C. M., Chiocca E. A., Weissleder R., Breakefield XO. Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum Gene Ther 1995; 6: 1543–1552
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Aebersold P., Cornetta K., Kasid A., Morgan R. A., Moen R., Karson E. M., Lotze M. T., Yang J. C., Topalian SL, et al. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990; 323: 570–578
   PubMed Web of Science ®Google Scholar
• Ruff M., Schiffman E., Terranova V., Pert CB. Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. Clin Immuno and Immunopath 1985; 37: 387–396
   PubMedGoogle Scholar
• Russel S. J., Hawkins R. E., Winter G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 1995; 21: 1081–1085
   Google Scholar
• Saris S. C., Spiess P., Lieberman D. M., Lin S., Walbridge S., Oldfield EH. Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes. J Neurosurg 1992; 76: 513–519
   Google Scholar
• Schiffer D., Cavalla P., Dutto A., Borsotti L. Cell proliferation and invasion in malignant gliomas. Anticancer Res 1997; 17: 61–69
   Google Scholar
• Schnierle B. S., Groner G. Retroviral targeted delivery. Gene Ther 1996a; 3: 1069–1073
   PubMed Web of Science ®Google Scholar
• Schnierle B. S., Moritz D., Jeschke M., Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Therapy 1996b; 3: 334–342
   Google Scholar
• Schoof D. D., Gramolini C. A., Davidson D. L., Massaro A. F., Wilson R. E., Eberlein TJ. Adoptive immuno-therapy of human cancer using low-dose recombinant interleukin-2 and lymphokine-activated killer cells. Cancer Res 1988; 48: 5007–5010
   PubMed Web of Science ®Google Scholar
• Schwarzenberger P., Spence S. E., Gooya JM, Michiel D., Curiel D. T., Ruscetti F. W., Keller JR. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 1996; 87: 472–8
   PubMed Web of Science ®Google Scholar
• Scott J. K., Smith GP. Searching for peptide ligands with an epitope library. Science 1990; 249: 386–390
   PubMed Web of Science ®Google Scholar
• Sherman M. L., Datta R., Hallahan D. E., Weichselbaum R. R., Kufe DW. Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci USA 1990; 87: 5663–5666
   PubMed Web of Science ®Google Scholar
• Shimizu K. Selective gene therapy of malignant gliomas using brain-specific promoters: its efficacy and basic investigation. Nippon Rinsho 1994; 52: 3053–3058, (Japanese J Clin Med)
   Google Scholar
• Shin T. H., Paterson A. J., Kudlow JE. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53. Mol Cell Bio 1995; 15: 4694–4701
   PubMedGoogle Scholar
• Short M. P., Choi B., Lee J., Malick A., Breakefield X. O., Martuza RL. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res 1990; 27: 427–439
   PubMed Web of Science ®Google Scholar
• Shu S., Chou T., Rosenberg SA. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. J Immunol 1987; 139: 295–304
   PubMed Web of Science ®Google Scholar
• Smith M. J., Rousculp M. D., Goldsmith K. T., Curiel D. T., Garver RK. Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. Hum Gene Ther 1994; 5: 29–35
   PubMed Web of Science ®Google Scholar
• Snyder E. Y., Deitcher D. L., Walsh C., Arnold-Aldea S., Hartweig E. A., Cepko CL. Multipotent neuronal cell lines can engraft and participate in development of mouse cerebellum. Cell 1992; 68: 33–51
   PubMed Web of Science ®Google Scholar
• Somia N. V., Zoppe M., Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci 1995; 92: 7570–7574
   PubMedGoogle Scholar
• Spear M. A., Li C., Weissleder R., Putney S., Pechan P., Breakefield XO. 0x26 Monoclonal Antibody Targets HSV-1 Vector to Transferrin Receptor-Bearing Cells. Proc Am Assoc Cancer Res 1997; 38: 343, (A2302)
   Google Scholar
• Spear M. A., Sakamoto K. M., Herrlinger U., Pechan P. P., Bxeakfield XO. Function of the EGR-1 promoter in a minimal HSV-1 amplicon vector system. Proc Am Soc Ther Rad Oncol 1997, (In press)
   Google Scholar
• Stevens C. W., Zeng M., Cerniglia GJ. Ionizing radiation greatly improves gene transfer efficiency in mammalian cells. Hum Gene Ther 1996; 7: 1727–1734
   PubMed Web of Science ®Google Scholar
• Takahashi J. A., Fukumoto M., Igarashi K., Oda Y., Kikuchi H., Hatanaka M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 1992; 76: 792–798
   PubMed Web of Science ®Google Scholar
• Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J. C., Abraham JA. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947–11954
   PubMed Web of Science ®Google Scholar
• Urien S., Pinquier J. L., Paquette B., Chaumet-Riffaud P., Kiochel J. P., Tillement JP. Effect of the binding of isradipine and darodapine to different plasma proteins and their transfer through the rat blood-brain barrier: drug binding to lipoproteins does not limit the transfer of drug. J Pharmacol Exp Ther 1987; 242: 349–353
   PubMed Web of Science ®Google Scholar
• Ventimiglia J. B., Wikstrand C. J., Ostrowdki L. E., Bourdon M. A., Lightner V. A., Bigner DD. Tenascin expression in human glioma cell lines and normal tissues. J Neuroimmunol 1992; 36: 41–55
   PubMed Web of Science ®Google Scholar
• Vile R. G., Miller N., Chernajovsky Y., Hart I. Ca comparison of the properties of different retroviral vectors containing the mutine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes. Gene Ther 1994; 1: 307–316
   PubMed Web of Science ®Google Scholar
• Vile R. G., Diaz R. M., Miller N., Mitchell S., Russell SJ. Tissue-specific gene expression form Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter. Virology 1995; 214: 307–313
   PubMedGoogle Scholar
• Vile R. G., Hart IR. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962–967
   PubMed Web of Science ®Google Scholar
• Vitolo D., Zerbe T., Kanbour A., Dahl C., Herberman R. B., Whiteside TL. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 1992; 51: 573–580
   PubMedGoogle Scholar
• Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D. T., Birnstiel ML. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci 1992; 89: 6099–6103
   PubMed Web of Science ®Google Scholar
• Walker M. D., Alexander E., Hunt W. E., Maccarty C. S., Mahaley M. S., Mealey J., Norrell H. A., Owens G., Ransohoff J., Wilson C. B., Gehan E. A., Strike TA. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978; 49: 333–343
   PubMed Web of Science ®Google Scholar
• Wang Q., Redovan C., Tubbs R., Olencki T., Klein E., Kudoh S., Finke J., Bukowski RM. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer 1995; 61: 780–785
   PubMed Web of Science ®Google Scholar
• Wang Y., Tsai S. Y., O'Malley BW. A regulatory system for use in gene transfer. Proc Natl Acad Sci 1994; 91: 8180–8184
   PubMed Web of Science ®Google Scholar
• Weijtens M., Willemsen R., Valerio D., Stam K., Bolhuis R. Functional expression of a single chain Fv/g receptor with renal cell carcinoma specificity in activated human PBL; single chain antibody Fv fragment and FceRI receptor fusion gene expression in cytotoxic T-lymphocyte or peripheral blood lymphocyte using LXSN retro virus vector (abstract). J Mol Med 1995; 73: B13
   Google Scholar
• Weindel K., Moringlane J. R., Marme D., Weich HA. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?. 1994
   Google Scholar
• Weischelbaum R. R., Hallahan D. E., Becket M. A., Hauceri H. J., Lee H., Sukhatme V. P., Kufe DW. Gene Therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 1994; 54: 4266–4269
   Google Scholar
• Weller M., Fontana A. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-B, T-cell apoptosis, and the immune privilege of the brain. Brain Res Rev 1995; 21: 128–151
   PubMed Web of Science ®Google Scholar
• Weller R. O., Engelhardt B., Phillips M. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathology 1996; 6: 275–288
   PubMed Web of Science ®Google Scholar
• Whelan J., Miller N. Generation of estrogen receptor mutants with altered ligand specificity for use in establishing regulatable gene expression system. J Steroid Biochem Mol Biol 1996; 58: 3–12
   Google Scholar
• Wickham T. J., Segal D. M., Roelvink P. W., Carrion M. E., Lizonova A., Lee G. M., Kovesdi I. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol 1996; 70: 6831–6838
   PubMed Web of Science ®Google Scholar
• Yamada S., Ruscetti F. W., Overton W. R., Herberman R. B., Birchenall-Sparks M. C., Ortaldo JR. Regulation of human large granular lymphocytes and T cell growth and function by recombinant interleukin 2. I. Induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity. J Leukocyte Biol 1987; 41: 505
   PubMed Web of Science ®Google Scholar
• Yanase T., Tamura M., Fujita K., Kodama S., Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 1993; 53: 2566–2570
   PubMed Web of Science ®Google Scholar
• Yoshida S., Tanaka R., Ono M., Takai N., Saito T. Analysis of mixed lymphocyte-tumor culture in patients with malignant brain tumor. J Neurosurg 1989; 71: 398–402
   Google Scholar
• Yuan F., Dellian M., Fukumura D., Leunig M., Berk D. A., Torchilin V. P., Jain RK. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995; 55: 3752–3756
   PubMed Web of Science ®Google Scholar
• Zalutsky M. R., Moseley R. P., Coakham H. B., Coleman R. E., Bigner DD. Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies. Cancer Res 1989; 49: 2807–2813
   PubMed Web of Science ®Google Scholar
• Zimmerman L., Parr B., Lendahl U., Cunningham M., Mckay R., Gavin B., Mann J., Vassileva G., Mcmahon A. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 1994; 12: 11–24
   PubMed Web of Science ®Google Scholar
• Ziinkeller B., Carson R. E., Olson J., Blasberg R. G., Devroom H., Lutz R. J., Saris S. C., Wright D. C., Kammerer W., Patronas N. J., Dedrick R. L., Herscovitch P., Oldfield EH. Quantification and pharmacokinetics of blood-brain barrier disruption in humans. J Neurosurg 1996; 85: 1056–1065
   Google Scholar